Gland Pharma Limited (Gland), a leading generic injectable-focused pharmaceutical company, has secured significant approval from the United States Food and Drug Administration (USFDA) for its Plerixafor Injection. This marks a strategic expansion of Gland’s oncology portfolio within the crucial US market. Approved Product Details The USFDA-approved Plerixafor Injection is available in a 24 mg/1.2 mL …